At a Glance
Your Trusted CDMO Partner
-
Global Clients
100+
-
Employees
4,400+
-
Global Regulatory
Approvals
-
Total Capacity
604 kL + Plant 5 *
Plant 1
30,000 L
Plant 2
154,000 L
Plant 3
180,000 L
Plant 4
240,000 L
Plant 5
180,000 L *
* To be operational in April 2025
- Awards
-
By consistently delivering superior client satisfaction through execution excellence and innovation, Samsung Biologics has been selected by our clients for the CDMO Leadership Awards for
11 consecutive years.
- CDMO LEADERSHIP AWARDS 2024
-
CDMO LEADERSHIP AWARDS 2024 CAPABILITIES
CDMO LEADERSHIP AWARDS 2024 COMPATIBILITY
CDMO LEADERSHIP AWARDS 2024 EXPERTISE
CDMO LEADERSHIP AWARDS 2024 QUALITY
CDMO LEADERSHIP AWARDS 2024 RELIABILITY
CDMO LEADERSHIP AWARDS 2024 SERVICE
CDMO LEADERSHIP AWARDS 2024
CDMO LEADERSHIP AWARDS 2024 CAPABILITIES
CDMO LEADERSHIP AWARDS 2024 COMPATIBILITY
CDMO LEADERSHIP AWARDS 2024 EXPERTISE
CDMO LEADERSHIP AWARDS 2024 QUALITY
CDMO LEADERSHIP AWARDS 2024 RELIABILITY
CDMO LEADERSHIP AWARDS 2024 SERVICE
Global Regulatory Approvals
- 2015
-
FDA : 1
Total : 1
- 2016
-
EMA : 4
FDA : 3
Total : 7
- 2017
-
Others : 4
EMA : 5
FDA : 4
Total : 13
- 2018
-
Others : 8
EMA : 7
FDA : 8
Total : 23
- 2019
-
Others : 38
EMA : 12
FDA : 9
Total : 59
- 2020
-
Others : 64
EMA : 15
FDA : 15
Total : 94
- 2021
-
Others : 107
PMDA : 0
EMA : 19
FDA : 17
Total : 143
- 2022
-
Others : 165
EMA : 25
FDA : 24
Total : 214
- 2023
-
Others : 219
EMA : 31
FDA : 30
Total : 280
- 2024
-
Others : 268
EMA : 33
FDA : 38
Total : 339
Number of Approvals | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
FDA | 1 | 3 | 4 | 8 | 9 | 15 | 17 | 24 | 30 | 38 |
EMA | 4 | 5 | 7 | 12 | 15 | 19 | 25 | 31 | 33 | |
Others (PMDA, MFDS, and etc.) |
4 | 8 | 38 | 64 | 107 | 165 | 219 | 268 | ||
Cumulative Total | 1 | 7 | 13 | 23 | 59 | 94 | 143 | 214 | 280 | 339 |